CAB molecules
US8088609B2 · kind B2 · utility
0Cited by
11References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2005 |
| Grant date | Jan 3, 2012 |
| Priority date | — |
| Expiry date | Oct 2, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to CAB molecules, ADEPT constructs directed against CEA, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.